BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3281171)

  • 1. Cytotoxic action and other metabolic consequences of terminal complement proteins.
    Shin ML; Carney DF
    Prog Allergy; 1988; 40():44-81. PubMed ID: 3281171
    [No Abstract]   [Full Text] [Related]  

  • 2. The functional significance of complement.
    Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
    Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
    [No Abstract]   [Full Text] [Related]  

  • 3. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemistry and function of the complement system.
    Müller-Eberhard HJ
    Hosp Pract; 1977 Aug; 12(8):33-43. PubMed ID: 892784
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
    Spitzer R; Stitzel A; Florio L; Urmson J
    Immunochemistry; 1976 May; 13(5):395-400. PubMed ID: 780264
    [No Abstract]   [Full Text] [Related]  

  • 6. [C6, C7, C8 and C9].
    Hatanaka M; Kitano E
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():90-3. PubMed ID: 20942009
    [No Abstract]   [Full Text] [Related]  

  • 7. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of the terminal complement proteins, C5-C9, by human platelets.
    Houle JJ; Leddy JP; Rosenfeld SI
    Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
    Hänsch GM; Hammer CH; Vanguri P; Shin ML
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5118-21. PubMed ID: 6946459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologically mediated membrane damage: the mechanism of complement action and the similarity of lymphocyte-mediated cytotoxicity.
    Mayer MM; Hammer CH; Michaels DW; Shin ML
    Transplant Proc; 1978 Dec; 10(4):707-14. PubMed ID: 366830
    [No Abstract]   [Full Text] [Related]  

  • 11. The C5b-6 complex: reaction with C7, C8, C9.
    Podack ER; Biesecker G; Kolb WP; Müller-Eberhard HJ
    J Immunol; 1978 Aug; 121(2):484-90. PubMed ID: 681745
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement system].
    Korol' SA
    Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 15. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.
    Hu VW; Esser AF; Podack ER; Wisnieski BJ
    J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-situ complement activation, pulmonary hypertension and vascular leakage in rabbit lungs--the role of the terminal complement complex.
    Seeger W; Hartmann R; Neuhof H; Bhakdi S
    Prog Clin Biol Res; 1989; 308():283-9. PubMed ID: 2675053
    [No Abstract]   [Full Text] [Related]  

  • 18. Deviated lysis: transfer of complement lytic activity to unsensitized cells. I. Generation of the transferable activity on the surface of complement resistant bacteria.
    Rother U; Hänsch G; Menzel J; Rother K
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):172-86. PubMed ID: 4283273
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
    Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
    [No Abstract]   [Full Text] [Related]  

  • 20. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.